Revising these proposals has also been an opportune moment to further strengthen the current system for monitoring the safety of medicines (known as the pharmacovigilance system) in the European Union.
Ettepanekute läbivaatamine on andnud ka hea võimaluse tugevdada praegust ravimiohutuse järelevalve süsteemi Euroopa Liidus.